UK Edition
AdvertiseSubmit Company
Pharma JournalEvidence-Based Pharmaceutical Intelligence
CLINICAL RESEARCH

Excellerate Bioscience

Bioprocess development and manufacturing services for biologics

Excellerate Bioscience logo

Excellerate Bioscience

Clinical ResearchUnited Kingdom

Bioprocess development and manufacturing services for biologics

Visit WebsiteContact Company

About Excellerate Bioscience

Excellerate Bioscience was established in 2016 with a clear mandate: to bring together the best of academic and industrial drug discovery science within a single, agile contract research organisation. Headquartered in the United Kingdom, the company provides molecular and cellular pharmacology services to clients engaged in drug discovery, combining scientific creativity with collaborative working practices.

The company's approach centres on improving the efficiency and translatability of in vitro pharmacological profiling. Its experienced team of drug discovery scientists is organised to deliver both rigour and flexibility, qualities that organisations working at early discovery stages often require from external partners.

Excellerate Bioscience's service portfolio spans several key areas of preclinical research. Capabilities include molecular pharmacology, phenotypic assays, screening and assay development, and work across multiple drug modalities. The company also supports clients through distinct drug discovery phases, with therapeutic area coverage built into its project delivery model. This breadth allows it to serve partners from early target identification through to candidate selection.

With its founding team drawn from both academic and pharmaceutical industry backgrounds, the organisation was built to address a recognised gap: providing high-quality, scientifically innovative pharmacology services with the responsiveness that larger service providers can struggle to match. The mission stated at formation remains central to how the company operates today.

Further information is available at excelleratebio.com.

Areas of Expertise

Drug DiscoveryPreclinical Research

Services & Capabilities

Drug DiscoveryPreclinical Research
Similar Companies

More in Clinical Research

A

ARC Regulatory

Regulatory navigation for IVD and companion diagnostics sits at the core of what ARC Regulatory does. The firm operates as a specialist contract research organisation serving pharmaceutical, diagnostics and laboratory clients that require expert guidance through the clinical and compliance demands of in vitro diagnostic and CDx development. The service portfolio spans four principal disciplines. On the regulatory side, the team supports clients in navigating global frameworks applicable to IVD and CDx programmes. Clinical monitoring is delivered with a global presence, with a particular focus on IVD and CDx study designs. Quality services cover QMS auditing, risk management and QMS implementation, while ARC Research Laboratories provides IVD development and validation using advanced technologies. The CRO offering guides sponsors from strategy through to study close-out across every phase of IVD and CDx clinical development. A dedicated IVD Clinical Study Sponsor Delegation service allows clients to initiate and manage IVD studies through a single trusted partner. The firm's proprietary ARC360 platform is positioned to accelerate clinical performance studies, supporting monitoring of central testing laboratories across the full clinical development life-cycle. Sector coverage reflects the firm's cross-disciplinary positioning. Pharmaceutical clients benefit from support in translational biomarker programmes and early clinical trial authorisations, including risk-based monitoring of central testing laboratories. Diagnostics companies receive R&D compliance support and full-service CRO capability for clinical performance studies. Laboratory clients access analytical testing capabilities aligned to their regulatory obligations. Further information is available at arc-regulatory.co.uk.

View profile
R

RSSL

RSSL (Reading Scientific Services) operates across two major industry verticals, providing contract laboratory and scientific services to clients in life sciences and pharmaceuticals as well as food and consumer goods. Based in Reading, UK, the organisation positions itself as an outsourced testing and innovation partner covering everything from early research and discovery through to manufacturing, commercialisation, and regulatory compliance. Within the pharmaceutical and life science sector, RSSL offers testing across a broad range of molecule and product types, including biologics, cell and gene therapy, consumer healthcare, small molecule pharmaceuticals, vaccines, veterinary medicine, and specialised nutritional products. Services are organised by development phase, allowing clients to engage at preclinical stages, through clinical development, and into commercial-scale manufacturing. Capabilities span pharmacopoeial testing, ICH stability studies, contamination and impurity analysis, microbiology testing, and a rapid mycoplasma screening and detection service, which the company describes as fast, compliant, and sensitive. A priority response service is also available for time-critical projects. RSSL maintains an Innovation Hub and a dedicated services directory spanning techniques and methods to support product development across its client base. The food and consumer goods division extends these analytical capabilities into food and beverages, ingredients, consumer goods, food service, specialised nutrition, nutraceuticals, and dietary supplements. A recently announced dedicated nutritional testing service, supported by a £1.2 million investment, reflects continued capital commitment to expanding laboratory capacity in this area. Further information is available at rssl.com.

View profile
4

4MCS

With a cumulative team experience of over 130 years in clinical trials and the pharmaceutical industry, 4MCS (4 Medical Clinical Solutions) operates as a patient-centred Site Management Organisation dedicated to improving the quality of research in healthcare. The organisation runs its own network of research sites and recruits volunteers from a patient population of over 10 million, giving sponsors direct access to well-characterised cohorts without the delays associated with conventional site activation. The therapeutic breadth across the site's active clinical trial programme spans respiratory conditions including asthma and COPD, cardiovascular disease areas such as atrial fibrillation and hypertension, metabolic and hepatic conditions including fatty liver disease, and a range of central nervous system and dermatological indications. Migraine, depression, general anxiety disorder, myasthenia gravis, lower back pain, psoriasis, and premenopausal effects on sexual health are among the specific areas where the organisation is actively recruiting or conducting clinical research. The patient-centred model that underpins the 4MCS approach prioritises participant experience alongside data quality, with a stated mission linked to improving patient quality of life through evidence generation. The organisation maintains dedicated disease and therapy area specialisms within its leadership and operations structure, supported by an established research site infrastructure across the United Kingdom. Further information is available at 4mcs.co.uk.

View profile
AdvertisementTeksyte LTD

List Your Company

Showcase your company to thousands of pharma professionals.

Submit Listing

Advertise With Us

Reach decision-makers in the pharmaceutical industry.

Learn More

We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy